Makeup company L’Oréal has recalled popular brand La Roche-Posay’s acne cream because it may contain benzene, a ...

Spanning 23,226 sqm, the new $160m research and innovation centre will focus on developing products for its North American ...

The Maybelline and CeraVe product manufacturer aims to bolster its portfolio with innovations from its largest U.S. research ...

The $160 million investment in the nearly 250,000-square-foot, state-of-the-art scientific research center is L'Oréal's ...

La Roche-Posay’s Effaclar Duo Dual-Action Acne Treatment is being recalled because products containing benzoyl peroxide could ...

“We are opening a new era and chapter of innovation,” said Barbara Lavernos, deputy CEO of L’Oréal, in an exclusive interview ...

Nicolas Hieronimus, CEO of L’Oréal, talks about its new R&I Center in NJ and U.S. tariff impacts—watch CNBC's exclusive ...

L’Oréal Groupe has completed the development of its new North America Research & Innovation (R&I) Center located in Clark, New Jersey, marking a significant milestone in the cosmetic company ...

With Today's Ribbon-Cutting Event, New R&I Center Becomes Flagship in L'Oréal's Global Scientific Research Ecosystem, Second Largest Outside France, Employing More than 600 Scientists Barbara ...

Parent company La Roche-Posay has pulled the Effaclar Duo Acne Spot Treatment from L'Oreal's lineup, due to a cancer-causing carcinogen contamination.

Beauty product maker L’Oréal Groupe opened last week a $160 million research and development facility in Clark, New Jersey ... The center is L’Oreal’s largest research facility outside ...